Infectious diseases continue to pose severe threats to health systems everywhere. At CQMED, we are developing an integrated research program to find solutions to prevent and treat both emergent and recurring infectious diseases. One of our major focuses is the emergence of antibiotic-resistant bacteria and Neglected Tropical Diseases (NTD), such as leishmaniasis. At CQMED we employ state-of-the-art technologies to identify new therapeutic targets and develop new small molecules as antimicrobials.
M4K Pharma, a pharmaceutical company with a Open Science Philosophy for Children´s health
Jan 11, 2019
Jun 04, 2020
27 de setembro de 2021CQMED lança vídeos sobre expressão e purificação de proteínas
12 de fevereiro de 2021Cientistas descobrem moléculas que desaceleram o desenvolvimento de câncer cerebral